Search | VHL CLAP/WR-PAHO/WHO

1.

Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: primary analysis of the CAPTIVATE FD cohort.

Tam, Constantine S; Allan, John N; Siddiqi, Tanya; Kipps, Thomas J; Jacobs, Ryan; Opat, Stephen; Barr, Paul M; Tedeschi, Alessandra; Trentin, Livio; Bannerji, Rajat; Jackson, Sharon; Kuss, Bryone J; Moreno, Carol; Szafer-Glusman, Edith; Russell, Kristin; Zhou, Cathy; Ninomoto, Joi; Dean, James P; Wierda, William G; Ghia, Paolo.

Blood ; 139(22): 3278-3289, 2022 06 02.

Article in English | MEDLINE | ID: mdl-35196370

2.

Frontline Therapy in Chronic Lymphocytic Leukemia.

Arguello-Tomas, Miguel; Albiol, Nil; Moreno, Carol.

Acta Haematol ; 147(1): 47-59, 2024.

Article in English | MEDLINE | ID: mdl-37899041

3.

Fixed-duration ibrutinib-venetoclax versus chlorambucil-obinutuzumab in previously untreated chronic lymphocytic leukaemia (GLOW): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial.

Niemann, Carsten U; Munir, Talha; Moreno, Carol; Owen, Carolyn; Follows, George A; Benjamini, Ohad; Janssens, Ann; Levin, Mark-David; Robak, Tadeusz; Simkovic, Martin; Voloshin, Sergey; Vorobyev, Vladimir; Yagci, Munci; Ysebaert, Loic; Qi, Keqin; Qi, Qianya; Sinet, Pierre; Parisi, Lori; Srinivasan, Srimathi; Schuier, Natasha; Baeten, Kurt; Howes, Angela; Caces, Donne Bennett; Kater, Arnon P.

Lancet Oncol ; 24(12): 1423-1433, 2023 Dec.

Article in English | MEDLINE | ID: mdl-37944541

4.

Sequence matters: Total body irradiation (TBI)-based myeloablative conditioning with post-transplant cyclophosphamide may reduce the early nonrelapse mortality compared with pretransplant cyclophosphamide plus TBI.

Redondo, Sara; García-Cadenas, Irene; Vila, Antonio; Esquirol, Albert; Portos, J M; Novelli, Silvana; Saavedra, Silvana; Moreno, Carol; Garrido, Ana; Arguello-Tomas, Miguel; Oñate, Guadalupe; López-Pardo, Jordi; Caballero, Ana-Carolina; Miqueleiz, Sara; Briones, Javier; Sierra, Jorge; Sancho, Gemma; Martino, Rodrigo.

Eur J Haematol ; 111(1): 146-153, 2023 Jul.

Article in English | MEDLINE | ID: mdl-37058419

5.

Many People With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Benefit From Ibrutinib Treatment Up To 8 Years: A Plain Language Summary.

Barr, Paul M; Owen, Carolyn; Robak, Tadeusz; Tedeschi, Alessandra; Bairey, Osnat; Burger, Jan A; Hillmen, Peter; Dearden, Claire; Grosicki, Sebastian; McCarthy, Helen; Li, Jian Yong; Offner, Fritz; Moreno, Carol; Jermain, Mandy; Zhou, Cathy; Hsu, Emily; Szoke, Anita; Kipps, Thomas J; Ghia, Paolo.

Future Oncol ; 2023 01 09.

Article in English | MEDLINE | ID: mdl-36617990

6.

Long-term efficacy of first-line ibrutinib treatment for chronic lymphocytic leukaemia in patients with TP53 aberrations: a pooled analysis from four clinical trials.

Allan, John N; Shanafelt, Tait; Wiestner, Adrian; Moreno, Carol; O'Brien, Susan M; Li, Jianling; Krigsfeld, Gabriel; Dean, James P; Ahn, Inhye E.

Br J Haematol ; 196(4): 947-953, 2022 02.

Article in English | MEDLINE | ID: mdl-34865212

7.

First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab: final analysis of the randomized, phase III iLLUMINATE trial.

Moreno, Carol; Greil, Richard; Demirkan, Fatih; Tedeschi, Alessandra; Anz, Bertrand; Larratt, Loree; Simkovic, Martin; Novak, Jan; Strugov, Vladimir; Gill, Devinder; Gribben, John G; Kwei, Kevin; Dai, Sandra; Hsu, Emily; Dean, James P; Flinn, Ian W.

Haematologica ; 107(9): 2108-2120, 2022 09 01.

Article in English | MEDLINE | ID: mdl-35021599

8.

The road to chemotherapy-free treatment in chronic lymphocytic leukaemia.

Albiol, Nil; Arguello-Tomas, Miguel; Moreno, Carol.

Curr Opin Oncol ; 33(6): 670-680, 2021 11 01.

Article in English | MEDLINE | ID: mdl-34474439

9.

Long-term follow-up of the RESONATE phase 3 trial of ibrutinib vs ofatumumab.

Byrd, John C; Hillmen, Peter; O'Brien, Susan; Barrientos, Jacqueline C; Reddy, Nishitha M; Coutre, Steven; Tam, Constantine S; Mulligan, Stephen P; Jaeger, Ulrich; Barr, Paul M; Furman, Richard R; Kipps, Thomas J; Thornton, Patrick; Moreno, Carol; Montillo, Marco; Pagel, John M; Burger, Jan A; Woyach, Jennifer A; Dai, Sandra; Vezan, Remus; James, Danelle F; Brown, Jennifer R.

Blood ; 133(19): 2031-2042, 2019 05 09.

Article in English | MEDLINE | ID: mdl-30842083

10.

Pretreatment with ibrutinib reduces cytokine secretion and limits the risk of obinutuzumab-induced infusion-related reactions in patients with CLL: analysis from the iLLUMINATE study.

Greil, Richard; Tedeschi, Alessandra; Moreno, Carol; Anz, Bertrand; Larratt, Loree; Simkovic, Martin; Gill, Devinder; Gribben, John G; Flinn, Ian W; Wang, Zhengyuan; Cheung, Leo W K; Nguyen, Aaron N; Zhou, Cathy; Styles, Lori; Demirkan, Fatih.

Ann Hematol ; 100(7): 1733-1742, 2021 Jul.

Article in English | MEDLINE | ID: mdl-34018029

11.

High-risk chronic lymphocytic leukemia in the era of pathway inhibitors: integrating molecular and cellular therapies.

Dreger, Peter; Ghia, Paolo; Schetelig, Johannes; van Gelder, Michel; Kimby, Eva; Michallet, Mauricette; Moreno, Carol; Robak, Tadeusz; Stilgenbauer, Stephan; Montserrat, Emili.

Blood ; 132(9): 892-902, 2018 08 30.

Article in English | MEDLINE | ID: mdl-29997221

12.

When an HLA identical donor is not available in adults with hematological neoplasms: single-center comparison of single-unit cord blood transplantation and haploidentical-related PBSC transplantation with PTCy using a standardized conditioning platform (thiotepa-busulfan-fludarabine).

Esquirol, Albert; Querol, Sergi; Garcia-Cadenas, Irene; Novelli, Silvana; Garrido, Ana; Saavedra, Silvana; Moreno, Carol; Granell, Miquel; Caballero, Ana; Brunet, Salut; Briones, Javier; Martino, Rodrigo; Sierra, Jorge.

Ann Hematol ; 99(1): 157-165, 2020 Jan.

Article in English | MEDLINE | ID: mdl-31844931

13.

Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial.

Moreno, Carol; Greil, Richard; Demirkan, Fatih; Tedeschi, Alessandra; Anz, Bertrand; Larratt, Loree; Simkovic, Martin; Samoilova, Olga; Novak, Jan; Ben-Yehuda, Dina; Strugov, Vladimir; Gill, Devinder; Gribben, John G; Hsu, Emily; Lih, Chih-Jian; Zhou, Cathy; Clow, Fong; James, Danelle F; Styles, Lori; Flinn, Ian W.

Lancet Oncol ; 20(1): 43-56, 2019 01.

Article in English | MEDLINE | ID: mdl-30522969

14.

Impact of ibrutinib dose adherence on therapeutic efficacy in patients with previously treated CLL/SLL.

Barr, Paul M; Brown, Jennifer R; Hillmen, Peter; O'Brien, Susan; Barrientos, Jacqueline C; Reddy, Nishitha M; Coutre, Steven; Mulligan, Stephen P; Jaeger, Ulrich; Furman, Richard R; Cymbalista, Florence; Montillo, Marco; Dearden, Claire; Robak, Tadeusz; Moreno, Carol; Pagel, John M; Burger, Jan A; Suzuki, Samuel; Sukbuntherng, Juthamas; Cole, George; James, Danelle F; Byrd, John C.

Blood ; 129(19): 2612-2615, 2017 05 11.

Article in English | MEDLINE | ID: mdl-28373262

15.

Final analysis from RESONATE: Up to six years of follow-up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma.

Munir, Talha; Brown, Jennifer R; O'Brien, Susan; Barrientos, Jacqueline C; Barr, Paul M; Reddy, Nishitha M; Coutre, Steven; Tam, Constantine S; Mulligan, Stephen P; Jaeger, Ulrich; Kipps, Thomas J; Moreno, Carol; Montillo, Marco; Burger, Jan A; Byrd, John C; Hillmen, Peter; Dai, Sandra; Szoke, Anita; Dean, James P; Woyach, Jennifer A.

Am J Hematol ; 94(12): 1353-1363, 2019 12.

Article in English | MEDLINE | ID: mdl-31512258

16.

Optimising outcomes for patients with chronic lymphocytic leukaemia on ibrutinib therapy: European recommendations for clinical practice.

Gribben, John G; Bosch, Francesc; Cymbalista, Florence; Geisler, Christian H; Ghia, Paolo; Hillmen, Peter; Moreno, Carol; Stilgenbauer, Stephan.

Br J Haematol ; 180(5): 666-679, 2018 03.

Article in English | MEDLINE | ID: mdl-29318593

17.

Autoimmune cytopenia and CLL ride together.

Moreno, Carol.

Blood ; 137(25): 3464-3465, 2021 06 24.

Article in English | MEDLINE | ID: mdl-34165542

18.

MRD in CLL: some answers, many questions.

Moreno, Carol; Mora, Alba.

Blood ; 138(26): 2746-2747, 2021 12 30.

Article in English | MEDLINE | ID: mdl-34967869

19.

Rituximab plus bendamustine or chlorambucil for chronic lymphocytic leukemia: primary analysis of the randomized, open-label MABLE study.

Michallet, Anne-Sophie; Aktan, Melih; Hiddemann, Wolfgang; Ilhan, Osman; Johansson, Peter; Laribi, Kamel; Meddeb, Balkis; Moreno, Carol; Raposo, João; Schuh, Anna; Ünal, Ali; Widenius, Tom; Bernhardt, Alf; Kellershohn, Kerstin; Messeri, Dimitri; Osborne, Stuart; Leblond, Véronique.

Haematologica ; 103(4): 698-706, 2018 04.

Article in English | MEDLINE | ID: mdl-29419437

20.

Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: extended phase 3 results from RESONATE-2.

Barr, Paul M; Robak, Tadeusz; Owen, Carolyn; Tedeschi, Alessandra; Bairey, Osnat; Bartlett, Nancy L; Burger, Jan A; Hillmen, Peter; Coutre, Steven; Devereux, Stephen; Grosicki, Sebastian; McCarthy, Helen; Li, Jianyong; Simpson, David; Offner, Fritz; Moreno, Carol; Zhou, Cathy; Styles, Lori; James, Danelle; Kipps, Thomas J; Ghia, Paolo.

Haematologica ; 103(9): 1502-1510, 2018 09.

Article in English | MEDLINE | ID: mdl-29880603

VHL CLAP/WR-PAHO/WHO

Latin-American Center for Perinatology, Woman and Reproductive Health

Config filters

Your selection (0)

Export format:

Export: